61 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
for SGLT2i in HF ... ASCVD or ASCVD risk ... ASCVD or ASCVD risk ... SGLT2 #inhibitors #EBM ... #trial #visualabstract
PAMPER - Prehospital Plasma during Air Medical Transport in Trauma Patients at Risk for Hemorrhagic Shock

N
Trauma Patients at Risk ... injured patients at risk ... Hemorrhagic #Shock #EMS #CriticalCare ... #VisualAbstract ... #EBM #Paramedic
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

CONCLUSIONS:
Among patients with heart failure and a
fraction, the risk ... Dapagliflozin #hfref #chf ... #visualabstract ... #ebm
Validation of the “Step-by-Step” Approach in the Management of Young Febrile Infants
Visual Abstract by Dr. Kirsty
pubmed/27382134 #EBM ... Peds #Pediatrics #VisualAbstract ... Febrile #Infant #Risk
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
ARRIVE - Moderate Risk ... mortality #Aspirin #VisualAbstract ... ASPREE #Management #EBM
Hospitalization for the Evaluation of Patients with Low Risk Chest Pain 
Choosing Wisely: Things We Do
Patients with Low Risk ... TWDFNR #Management #EBM ... #VisualAbstract
REVISE - Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical
increase in the risk ... #Prophylaxis #CriticalCare ... #Withholding #VisualAbstract ... #EBM
Functional Dyspepsia - Pathophysiology, Diagnosis and Management
Risk factors: Non-steroidal anti-inflammatory drugs, Psychological comorbidity, Helicobacter pylori infection,
Functional Dyspepsia - Pathophysiology ... and Management Risk ... sex, Smoking Symptoms ... : Bothersome symptoms ... Functional #Dyspepsia #Pathophysiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Heart Failure (CHF ... leading to: ↑ HF ... TSAT < 20% Risk ... Heart #Failure #CHF ... #pharmacology #pathophysiology
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
transfused patientsl • Risk ... blood donor • Pathophysiology ... ARDS to explain symptoms ... transfused patients • Risk ... : Age>60, CKD, CHF